APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Canine Influenza Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Canine Influenza Vaccine Market Outlook and Growth Opportunities 2026

Report ID 173974520420 December 2025196 pages

Choose your research edition.

Industry ResearchCanine Influenza Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Canine Influenza Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Canine Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Canine Influenza Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Canine Influenza Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Canine Influenza Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Canine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Canine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Canine Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Canine Influenza Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Canine Influenza Vaccine market include Bharat Biotech, CNBG, CSL Limited, LIAONING CHENGDA, Merck Animal Health, GSK, Roche, Novartis and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Canine Influenza Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Canine Influenza Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Canine Influenza Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Canine Influenza Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Canine Influenza Vaccine Segment by Company

Bharat Biotech

CNBG

CSL Limited

LIAONING CHENGDA

Merck Animal Health

GSK

Roche

Novartis

Zoetis

Canine Influenza Vaccine Segment by Type

H3N2 Vaccine

H3N8 Vaccine

Canine Influenza Vaccine Segment by Application

Vaccination Clinic

Pet Hospital

Others

Canine Influenza Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Canine Influenza Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Canine Influenza Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Canine Influenza Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Canine Influenza Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canine Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Canine Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canine Influenza Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Canine Influenza Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Canine Influenza Vaccine industry.

Chapter 3: Detailed analysis of Canine Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Canine Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Canine Influenza Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Canine Influenza Vaccine Industry Trends Table 2. Canine Influenza Vaccine Industry Drivers Table 3. Canine Influenza Vaccine Industry Opportunities and Challenges Table 4. Canine Influenza Vaccine Industry Restraints Table 5. Global Canine Influenza Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Canine Influenza Vaccine Revenue Share by Company (2021-2026) Table 7. Global Canine Influenza Vaccine Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Canine Influenza Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Canine Influenza Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Canine Influenza Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Canine Influenza Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Canine Influenza Vaccine Company, Product Type & Application Table 13. Global Canine Influenza Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Canine Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of H3N2 Vaccine Table 18. Significant Companies of H3N8 Vaccine Table 19. Global Canine Influenza Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Canine Influenza Vaccine Sales Volume by Type (2021-2026) & (W Units) Table 21. Global Canine Influenza Vaccine Sales Volume by Type (2027-2032) & (W Units) Table 22. Global Canine Influenza Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Canine Influenza Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Canine Influenza Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Canine Influenza Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Canine Influenza Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Canine Influenza Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Canine Influenza Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Vaccination Clinic Table 30. Significant Companies of Pet Hospital Table 31. Significant Companies of Others Table 32. Global Canine Influenza Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Canine Influenza Vaccine Sales Volume by Application (2021-2026) & (W Units) Table 34. Global Canine Influenza Vaccine Sales Volume by Application (2027-2032) & (W Units) Table 35. Global Canine Influenza Vaccine Sales Volume Share by Application (2021-2026) Table 36. Global Canine Influenza Vaccine Sales Volume Share by Application (2027-2032) Table 37. Global Canine Influenza Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Canine Influenza Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Canine Influenza Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Canine Influenza Vaccine Sales Value Share by Application (2021-2026) Table 41. Global Canine Influenza Vaccine Sales Value Share by Application (2027-2032) Table 42. Global Canine Influenza Vaccine Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Canine Influenza Vaccine Sales by Region (2021-2026) & (W Units) Table 44. Global Canine Influenza Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Canine Influenza Vaccine Sales by Region (2027-2032) & (W Units) Table 46. Global Canine Influenza Vaccine Sales Market Share by Region (2027-2032) Table 47. Global Canine Influenza Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Canine Influenza Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Canine Influenza Vaccine Sales Value Share by Region (2021-2026) Table 50. Global Canine Influenza Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Canine Influenza Vaccine Sales Value Share by Region (2027-2032) Table 52. Global Canine Influenza Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Canine Influenza Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Canine Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Global Canine Influenza Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 57. Global Canine Influenza Vaccine Sales Market Share by Country (2021-2026) Table 58. Global Canine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 59. Global Canine Influenza Vaccine Sales Market Share by Country (2027-2032) Table 60. Global Canine Influenza Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Canine Influenza Vaccine Sales Value Market Share by Country (2021-2026) Table 62. Global Canine Influenza Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Canine Influenza Vaccine Sales Value Market Share by Country (2027-2032) Table 64. Bharat Biotech Company Information Table 65. Bharat Biotech Business Overview Table 66. Bharat Biotech Canine Influenza Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Bharat Biotech Canine Influenza Vaccine Product Portfolio Table 68. Bharat Biotech Recent Development Table 69. CNBG Company Information Table 70. CNBG Business Overview Table 71. CNBG Canine Influenza Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. CNBG Canine Influenza Vaccine Product Portfolio Table 73. CNBG Recent Development Table 74. CSL Limited Company Information Table 75. CSL Limited Business Overview Table 76. CSL Limited Canine Influenza Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. CSL Limited Canine Influenza Vaccine Product Portfolio Table 78. CSL Limited Recent Development Table 79. LIAONING CHENGDA Company Information Table 80. LIAONING CHENGDA Business Overview Table 81. LIAONING CHENGDA Canine Influenza Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. LIAONING CHENGDA Canine Influenza Vaccine Product Portfolio Table 83. LIAONING CHENGDA Recent Development Table 84. Merck Animal Health Company Information Table 85. Merck Animal Health Business Overview Table 86. Merck Animal Health Canine Influenza Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Merck Animal Health Canine Influenza Vaccine Product Portfolio Table 88. Merck Animal Health Recent Development Table 89. GSK Company Information Table 90. GSK Business Overview Table 91. GSK Canine Influenza Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. GSK Canine Influenza Vaccine Product Portfolio Table 93. GSK Recent Development Table 94. Roche Company Information Table 95. Roche Business Overview Table 96. Roche Canine Influenza Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Roche Canine Influenza Vaccine Product Portfolio Table 98. Roche Recent Development Table 99. Novartis Company Information Table 100. Novartis Business Overview Table 101. Novartis Canine Influenza Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Novartis Canine Influenza Vaccine Product Portfolio Table 103. Novartis Recent Development Table 104. Zoetis Company Information Table 105. Zoetis Business Overview Table 106. Zoetis Canine Influenza Vaccine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Zoetis Canine Influenza Vaccine Product Portfolio Table 108. Zoetis Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Canine Influenza Vaccine Distributors List Table 112. Canine Influenza Vaccine Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Canine Influenza Vaccine Product Image Figure 2. Global Canine Influenza Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Canine Influenza Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Canine Influenza Vaccine Sales (2021-2032) & (W Units) Figure 5. Global Canine Influenza Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Canine Influenza Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. H3N2 Vaccine Image Figure 10. H3N8 Vaccine Image Figure 11. Global Canine Influenza Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Canine Influenza Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Canine Influenza Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Canine Influenza Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Canine Influenza Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Canine Influenza Vaccine Sales Value Share by Type (2021-2032) Figure 17. Vaccination Clinic Image Figure 18. Pet Hospital Image Figure 19. Others Image Figure 20. Global Canine Influenza Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Canine Influenza Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Canine Influenza Vaccine Sales Volume Share by Application (2021-2032) Figure 23. Global Canine Influenza Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Canine Influenza Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Canine Influenza Vaccine Sales Value Share by Application (2021-2032) Figure 26. Global Canine Influenza Vaccine Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 27. Global Canine Influenza Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Canine Influenza Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Canine Influenza Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Canine Influenza Vaccine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Canine Influenza Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Canine Influenza Vaccine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Canine Influenza Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Canine Influenza Vaccine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Canine Influenza Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Canine Influenza Vaccine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Canine Influenza Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Canine Influenza Vaccine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Canine Influenza Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Canine Influenza Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Canine Influenza Vaccine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Canine Influenza Vaccine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • H3N2 Vaccine
  • H3N8 Vaccine
Applications
  • Vaccination Clinic
  • Pet Hospital
  • Others
Companies covered
  • Bharat Biotech
  • CNBG
  • CSL Limited
  • LIAONING CHENGDA
  • Merck Animal Health
  • GSK
  • Roche
  • Novartis
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Canine Influenza Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Canine Influenza Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Canine Influenza Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Canine Influenza Vaccine Market Dynamics
  1. 2.1 Canine Influenza Vaccine Industry Trends
  2. 2.2 Canine Influenza Vaccine Industry Drivers
  3. 2.3 Canine Influenza Vaccine Industry Opportunities and Challenges
  4. 2.4 Canine Influenza Vaccine Industry Restraints
3 Canine Influenza Vaccine Market by Company
  1. 3.1 Global Canine Influenza Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Canine Influenza Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Canine Influenza Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Canine Influenza Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Canine Influenza Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Canine Influenza Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Canine Influenza Vaccine Company Product Type and Application
  8. 3.8 Global Canine Influenza Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Canine Influenza Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Canine Influenza Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Canine Influenza Vaccine Market by Type
  1. 4.1 Canine Influenza Vaccine Type Introduction
  2. 4.1.1 H3N2 Vaccine
  3. 4.1.2 H3N8 Vaccine
  4. 4.2 Global Canine Influenza Vaccine Sales Volume by Type
  5. 4.2.1 Global Canine Influenza Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Canine Influenza Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Canine Influenza Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Canine Influenza Vaccine Sales Value by Type
  9. 4.3.1 Global Canine Influenza Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Canine Influenza Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Canine Influenza Vaccine Sales Value Share by Type (2021-2032)
5 Canine Influenza Vaccine Market by Application
  1. 5.1 Canine Influenza Vaccine Application Introduction
  2. 5.1.1 Vaccination Clinic
  3. 5.1.2 Pet Hospital
  4. 5.1.3 Others
  5. 5.2 Global Canine Influenza Vaccine Sales Volume by Application
  6. 5.2.1 Global Canine Influenza Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Canine Influenza Vaccine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Canine Influenza Vaccine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Canine Influenza Vaccine Sales Value by Application
  10. 5.3.1 Global Canine Influenza Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Canine Influenza Vaccine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Canine Influenza Vaccine Sales Value Share by Application (2021-2032)
6 Canine Influenza Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Canine Influenza Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Canine Influenza Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Canine Influenza Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Canine Influenza Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Canine Influenza Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Canine Influenza Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Canine Influenza Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Canine Influenza Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Canine Influenza Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Canine Influenza Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Canine Influenza Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Canine Influenza Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Canine Influenza Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Canine Influenza Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Canine Influenza Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Canine Influenza Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Canine Influenza Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Canine Influenza Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Canine Influenza Vaccine Sales Value Share by Country, 2025 VS 2032
7 Canine Influenza Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Canine Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Canine Influenza Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Canine Influenza Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Canine Influenza Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Canine Influenza Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Canine Influenza Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Canine Influenza Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Canine Influenza Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Canine Influenza Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Canine Influenza Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Canine Influenza Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bharat Biotech
  2. 8.1.1 Bharat Biotech Company Information
  3. 8.1.2 Bharat Biotech Business Overview
  4. 8.1.3 Bharat Biotech Canine Influenza Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bharat Biotech Canine Influenza Vaccine Product Portfolio
  6. 8.1.5 Bharat Biotech Recent Developments
  7. 8.2 CNBG
  8. 8.2.1 CNBG Company Information
  9. 8.2.2 CNBG Business Overview
  10. 8.2.3 CNBG Canine Influenza Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CNBG Canine Influenza Vaccine Product Portfolio
  12. 8.2.5 CNBG Recent Developments
  13. 8.3 CSL Limited
  14. 8.3.1 CSL Limited Company Information
  15. 8.3.2 CSL Limited Business Overview
  16. 8.3.3 CSL Limited Canine Influenza Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CSL Limited Canine Influenza Vaccine Product Portfolio
  18. 8.3.5 CSL Limited Recent Developments
  19. 8.4 LIAONING CHENGDA
  20. 8.4.1 LIAONING CHENGDA Company Information
  21. 8.4.2 LIAONING CHENGDA Business Overview
  22. 8.4.3 LIAONING CHENGDA Canine Influenza Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 LIAONING CHENGDA Canine Influenza Vaccine Product Portfolio
  24. 8.4.5 LIAONING CHENGDA Recent Developments
  25. 8.5 Merck Animal Health
  26. 8.5.1 Merck Animal Health Company Information
  27. 8.5.2 Merck Animal Health Business Overview
  28. 8.5.3 Merck Animal Health Canine Influenza Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merck Animal Health Canine Influenza Vaccine Product Portfolio
  30. 8.5.5 Merck Animal Health Recent Developments
  31. 8.6 GSK
  32. 8.6.1 GSK Company Information
  33. 8.6.2 GSK Business Overview
  34. 8.6.3 GSK Canine Influenza Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GSK Canine Influenza Vaccine Product Portfolio
  36. 8.6.5 GSK Recent Developments
  37. 8.7 Roche
  38. 8.7.1 Roche Company Information
  39. 8.7.2 Roche Business Overview
  40. 8.7.3 Roche Canine Influenza Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Roche Canine Influenza Vaccine Product Portfolio
  42. 8.7.5 Roche Recent Developments
  43. 8.8 Novartis
  44. 8.8.1 Novartis Company Information
  45. 8.8.2 Novartis Business Overview
  46. 8.8.3 Novartis Canine Influenza Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Novartis Canine Influenza Vaccine Product Portfolio
  48. 8.8.5 Novartis Recent Developments
  49. 8.9 Zoetis
  50. 8.9.1 Zoetis Company Information
  51. 8.9.2 Zoetis Business Overview
  52. 8.9.3 Zoetis Canine Influenza Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Zoetis Canine Influenza Vaccine Product Portfolio
  54. 8.9.5 Zoetis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Canine Influenza Vaccine Value Chain Analysis
  2. 9.1.1 Canine Influenza Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Canine Influenza Vaccine Sales Mode & Process
  6. 9.2 Canine Influenza Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Canine Influenza Vaccine Distributors
  9. 9.2.3 Canine Influenza Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst